Literature DB >> 16762946

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.

Kenneth C Fearon1, Anne C Voss, Deborah S Hustead.   

Abstract

BACKGROUND: Cancer cachexia is a multifactorial syndrome that is poorly defined.
OBJECTIVE: Our objective was to evaluate whether a 3-factor profile incorporating weight loss (> or = 10%), low food intake (< or = 1500 kcal/d), and systemic inflammation (C-reactive protein > or = 10 mg/L) might relate better to the adverse functional aspects of cachexia and to a patient's overall prognosis than will weight loss alone.
DESIGN: One hundred seventy weight-losing (> or = 5%) patients with advanced pancreatic cancer were screened for nutritional status, functional status, performance score, health status, and quality of life. Patients were followed for a minimum of 6 mo, and survival was noted. Patients were characterized by using the individual factors, > or = 2 factors, or all 3 factors.
RESULTS: Weight loss alone did not define a population that differed in functional aspects of self-reported quality of life or health status and differed only in objective factors of physical function. The 3-factor profile identified both reduced subjective and objective function. In the overall population, the 3 factors, > or = 2 factors, and individual profile factors (except weight loss) all carried adverse prognostic significance (P < 0.01). Subgroup analysis showed that the 3-factor profile carried adverse prognostic significance in localized (hazard ratio: 4.9; P < 0.001) but not in metastatic disease.
CONCLUSIONS: Weight loss alone does not identify the full effect of cachexia on physical function and is not a prognostic variable. The 3-factor profile (weight loss, reduced food intake, and systemic inflammation) identifies patients with both adverse function and prognosis. Shortened survival applies particularly to cachectic patients with localized disease, thereby reinforcing the need for early intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16762946     DOI: 10.1093/ajcn/83.6.1345

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  203 in total

1.  A novel role for CD4+ T cells in the control of cachexia.

Authors:  Zhuangzhi Wang; Chunfang Zhao; Rosa Moya; Joanna D Davies
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.

Authors:  Mihael Sok; Janez Ravnik; Maja Ravnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.

Authors:  Pei-Hung Chang; Cheng-Hsu Wang; Eric Yen-Chao Chen; Shih-Wei Yang; Wen-Chi Chou; Jason Chia-Hsun Hsieh; Feng-Che Kuan; Kun-Yun Yeh
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

4.  JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.

Authors:  Scott E Mulder; Aneesha Dasgupta; Ryan J King; Jaime Abrego; Kuldeep S Attri; Divya Murthy; Surendra K Shukla; Pankaj K Singh
Journal:  Cancer Lett       Date:  2020-07-28       Impact factor: 8.679

5.  Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma.

Authors:  Motokazu Sugimoto; Michael B Farnell; David M Nagorney; Michael L Kendrick; Mark J Truty; Rory L Smoot; Suresh T Chari; Michael R Moynagh; Gloria M Petersen; Rickey E Carter; Naoki Takahashi
Journal:  J Gastrointest Surg       Date:  2018-02-01       Impact factor: 3.452

6.  Proteomic identification of potential markers of myosteatosis in human urine.

Authors:  Holger Husi; Alisdair MacDonald; Richard J E Skipworth; Janice Miller; Andrew Cronshaw; Kenneth C H Fearon; James A Ross
Journal:  Biomed Rep       Date:  2018-04-25

7.  Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.

Authors:  Laura Nemer; Somashekar G Krishna; Zarine K Shah; Darwin L Conwell; Zobeida Cruz-Monserrate; Mary Dillhoff; Denis C Guttridge; Alice Hinton; Andrei Manilchuk; Timothy M Pawlik; Carl R Schmidt; Erin E Talbert; Tanios Bekaii-Saab; Phil A Hart
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

Review 8.  Gaps in nutritional research among older adults with cancer.

Authors:  Carolyn J Presley; Efrat Dotan; Enrique Soto-Perez-de-Celis; Aminah Jatoi; Supriya G Mohile; Elizabeth Won; Shabbir Alibhai; Deepak Kilari; Robert Harrison; Heidi D Klepin; Tanya M Wildes; Karen Mustian; Wendy Demark-Wahnefried
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

Review 9.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

10.  Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma.

Authors:  E J Clark; S Connor; M A Taylor; K K Madhavan; O J Garden; R W Parks
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.